GTCBIO, Silver Spring
April 6-7, 2006
DAY 1 Thursday, April 6, 2006 7:00 Registration & Breakfast 8:00 Opening Remarks/Conference Goals CONFERENCE CHAIR: Richard Margolin, M.D., Senior Director, CNS (North America), i3Research Visiting Scholar, Laboratory of Molecular Imaging, David Geffen School of Medicine, UCLA 8:15 KEYNOTE PRESENTATION: Henry N. Wagner, Jr., M.D., Visiting Professor of Radiology, Director, Division of Nuclear Medicine, Vice Chairman for Technology and Business Development, Johns Hopkins Medical Institutions 9:00 TBA Barbara Y. Croft, Ph.D., Cancer Imaging Program, National Cancer Institute SESSION 1 - MODALITIES 9:30 Small Animal Optical Imaging Umar Mahmood, M.D., Ph.D., Center for Molecular Imaging Research, Massachusetts General Hospital, Harvard Medical School 10:00 30 MINUTE BREAK 10:30 The Role of PET in Drug Discovery with Focus on P-glycoprotein Functionality Philip Elsinga, University Medical Center Groningen 11:00 Imaging the Esophagogastric Transit of Pharmaceutical Dosage Forms Alan Perkins, PhD , FIPEM, ARCP, University Hospital of Nottingham 11:30 Oral Presentations from Selected Abstracts: In Vivo Assessment of Myocardial Function in Spironolactone Treated Insulin Resistant Rats via Cine Magnetic Resonance Imaging (MRI) Shawna Cooper, Sr. Research Specialist, Department of Internal Medicine-ENDO Sowers Lab, Harry S. Truman Veteran's Hospital Imaging of Cancer-Induced Bone Destruction using Micro Computed Tomography Andreas Evdokiou, The University of Adelaide 12:00 LUNCH SESSION 2 – APPLICATIONS IN ONCOLOGY & CARDIOLOGY 1:30 Imaging Science and Oncologic Drug Development G.J. Kelloff, National Cancer Institute 2:00 Optical Tomographic Small Animal Imaging System to Monitor Tumor Growth and Regression Andreas H. Hielscher, Ph.D., Associate Professor Departments of Biomedical Engineering & Radiology, Columbia University 2:30 Non-invasive Bioluminescence Imaging of Spontaneous Tumorigenesis and Angiogenesis in Mice Scott K. Lyons, Xenogen 3:00 In Vivo Monitoring of Human Embryonic Stem Cell-derived Graft Function in Living Animals using Optical Bioluminescence Imaging Technologies Michelle Bradbury, M.D., Ph.D., Memorial Sloan-Kettering Cancer Center 3:30 Refreshment Break 4:00 Tumor Imaging with Small Molecule Inhibitors Padmaja Yalamanchili, Ph.D.,Bristol Myers Squibb Medical Imaging 4:30 Atheroma: Developments in Imaging Surrogates of Risk Jonathan Gillard, BSc MD FRCR, University of Cambridge 5:00 KEYNOTE PRESENTATION: Strategic Role of Imaging in Drug Development: Structure and Function Helen Young, Ph.D., AstraZeneca 5:45 NETWORKING RECEPTION DAY 2 Friday, April 7, 2006 7:00 Registration & Breakfast SESSION 3– APPLICATIONS IN CNS 8:00 The Preclinical Development of CNS PET Radiotracers Shailendra Patel, Ph.D., Merck 8:30 The Development of Amyloid Specific Imaging Agents for Application in Alzheimer's Disease Andrew Lockhart, Ph.D., Neurology Biomarker Group, TMG, GlaxoSmithKline 9:00 PET Imaging of Amyloid Deposition using Pittsburgh Compound-B Julie Price, University of Pittsburgh 9:30 Refreshment Break 10:00 In Vivo Drug Effects on Dopaminergic System Bruce Jenkins, Ph.D., Instructor in Radiology, Director of Neurochemical Imaging Department of Radiology, MGH, Harvard Medical School 10:30 Imaging Techonology: Applications in CNS Richard Margolin, M.D., UCLA & i3Research SESSION 4 – BIOMARKERS 11:00 Imaging Biomarkers in Drug Development: An Overview of Opportunities and Open Issues Mac Johnson, Millennium Pharmaceuticals 11:30 Unique Challenges in the Discovery of Novel Imaging Agents: What is an Image-able Biomarker? Michael Montalto, Ph.D., GE Global Research 12:00 LUNCH SESSION 5 – CHALLENGES & OPPORTUNITIES 1:30 Utilizing Functional & Molecular Imaging Techniques Thomas Zeffiro, M.D., Ph.D., Director, GU Center for Functional and Molecular Imaging, Georgetown University 2:00 Challenges and Opportunities for Positron-emission Tomography in Personalized Medicine Suzanne V. Smith, Ph.D., Australian Nuclear Science & Technology Organization 2:30 Using Functional Magnetic Resonance Imaging in Awake Mice Gerard B Fox, Ph.D., Project Leader, Global Pharmaceutical Discovery, Abbott Laboratories 3:00 Refreshment Break 3:15 Commercialization of Research Tools Richard Smith, Edwards Angell Palmer & Dodge 3:45 How Can Imaging Reshape Clinical Research by Accelerating Medical Discovery? William C. Eckelman, Ph.D. Chief Scientific Officer, Molecular Tracer, LLC 4:15 CONFERENCE CONCLUDES
|